Anorexia Nervosa

Infantile Anorexia
Dr. Kennedy
http://fp.okstate.edu/

Coercion and the treatment of anorexia nervosa
http://www.childrensmercy.org/

Anorexia and Anorexia Athletica
By: Kayla Shinew
http://www.lhup.edu/

Activity Anorexia
http://pjackson.asp.radford.edu/

Eating Disorders Presentation
Becky Brandsberg-Herrera
http://ucs.truman.edu/

Eating Disorders
http://faculty.spokanefalls.edu/

Associated Features of Anorexia Nervosa
http://cte.rockhurst.edu/

Mortality Rate of Anorexia Nervosa
Jessie Gross
http://www.psy.fsu.edu/

Body Image Disturbance in Anorexia Nervosa
By Meghan Montgomery
http://www.psy.fsu.edu/

Anorexia & Bulimia
Antonella Magnelli
http://department.monm.edu/

Anorexia Nervosa
http://psychology.illinoisstate.edu/

Eating Disorders
http://homepages.gac.edu/

Eating Disorders In Athletes
http://extension.missouri.edu/

How to Narrow a Research Topic
http://liblearn.osu.edu/courses/

Anorexia nervosa
http://www.agls.uidaho.edu/

Anorexia Nervosa
Andrea Toro
http://campus.houghton.edu/


800 Published articles free access

1. The occupational roles of women with anorexia nervosa.
2. Comparison of a high-carbohydrate and highprotein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa.
3. Suprathreshold Duloxetine for Treatment-Resistant Depression, Anorexia Nervosa Binge-Purging type, and Obsessive-Compulsive Disorder: A Case Report.
4. Review of nutritional and dietary management of anorexia nervosa.
5. Leptin in anorexia and cachexia syndrome.
6. Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa.
7. Thinking about eating food activates visual cortex with reduced bilateral cerebellar activation in females with anorexia nervosa: an fMRI study.
8. Pulmonary Aspergilloma in Patient with Anorexia Nervosa: Case Report.
9. Endocrine alterations are the main determinants of cardiac remodelling in restrictive anorexia nervosa.
10. Somatic comorbidity in anorexia nervosa: First results of a 21-year follow-up study on female inpatients.
11. Cancer and anorexia nervosa in the adolescence: a family-based systemic intervention.
12. Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation.
13. Adolescent male with anorexia nervosa: a case report from Iraq.
14. A randomized controlled trial of adjunctive family therapy and treatment as usual following inpatient treatment for anorexia nervosa adolescents.
15. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans.
16. Bulimia and anorexia among the teenagers.
17. Cultural variability in Expressed Emotion among families of adolescents with anorexia nervosa.
18. The Eating Disorders Examination in adolescent males with anorexia nervosa: how does it compare to adolescent females?
19. The longitudinal BMI pattern and body composition of patients with anorexia nervosa who require urgent hospitalization: A case control study.
20. Anorexia nervosa: a unified neurological perspective.
21. Remission of anorexia nervosa after thyroidectomy: A report of two cases with Graves' disease and anorexia nervosa.
22. A case of anorexia nervosa complicated with strongly suspected stress-induced cardiomyopathy and mural thrombus.
23. A case of superior mesenteric artery syndrome caused by anorexia nervosa.
24. Restraint of appetite and reduced regional brain volumes in anorexia nervosa: a voxel-based morphometric study.
25. Neuropsychology and anorexia nervosa. Cognitive and radiological findings.
26. Hypothalamic mitochondrial dysfunction associated with anorexia in the anx/anx mouse.
27. Reproductive issues in anorexia nervosa.
28. Cognitive flexibility in verbal and nonverbal domains and decision making in anorexia nervosa patients: a pilot study.
29. Prescribing topiramate in patients with borderline personality disorder and a history of anorexia nervosa: a case report.
30. Resting Energy Expenditure in Anorexia Nervosa: Measured versus Estimated.
31. Bone mineral density accrual determines energy expenditure with refeeding in anorexia nervosa and supersedes return of menses.
32. Characteristics of suicide attempts in anorexia and bulimia nervosa: a case-control study.
33. Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures.
34. Differential neural responses to food images in women with bulimia versus anorexia nervosa.
35. Association of candidate genes with phenotypic traits relevant to anorexia nervosa.
36. Colonic pneumatosis intestinalis in a patient with neutropenia secondary to anorexia nervosa.
37. Hypokalemic nephropathy in anorexia nervosa.
38. Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?
39. Different Patterns of Emotional Eating and Visuospatial Deficits Whereas Shared Risk Factors Related with Social Support between Anorexia Nervosa and Bulimia Nervosa.
40. Food choice and diet variety in weight-restored patients with anorexia nervosa.
41. Anorexia nervosa and generalized anxiety disorder: further explorations of the relation between anxiety and body mass index.
42. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.
43. Altered fimbria-fornix white matter integrity in anorexia nervosa predicts harm avoidance.
44. Pathophysiology and treatment of inflammatory anorexia in chronic disease.
45. Diet and physical activity in women recovered from anorexia nervosa: a pilot study.
46. College students' perceptions of individuals with anorexia and bulimia nervosa.
47. Heightened sensitivity to reward and punishment in anorexia nervosa.
48. Nursing process to patients with anorexia nervosa.
49. Aggression and impulsivity with impulsive behaviours in patients with purgative anorexia and bulimia nervosa.
50. Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation.
51. Tako Tsubo cardiomyopathy, presenting with cardiogenic shock in a 24-year-old patient with anorexia nervosa.
52. Season of birth and anorexia nervosa.
53. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.
54. What can anorexia nervosa teach us about appetite regulation?
55. Steroid metabolism and excretion in severe anorexia nervosa: effects of refeeding.
56. The role of anorexia nervosa in secondary osteoporosis development with the risk for low energy fractures.
57. A young woman with anorexia, hypokalemia and convulsion.
58. Anorexia in adolescence--healthy in adulthood?
59. Anorexia nervosa: Russell's sign with concurrent tetany.
60. The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism.
61. GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism.
62. Management of sinus node dysfunction with junctional escape rhythm in a case of anorexia nervosa.
63. Premenopausal osteoporosis, an overlooked consequence of anorexia nervosa.
64. Family-based treatment of children and adolescents with anorexia nervosa: Guidelines for the community physician.
65. Optimal management of cancer anorexia-cachexia syndrome.
66. Estimated intelligence quotient in anorexia nervosa: a systematic review and meta-analysis of the literature.
67. Long-term misuse of zopiclone in an alcohol dependent woman with a history of anorexia nervosa: a case report.
68. Treatment of uraemic anorexia with megestrol acetate.
69. Young man with anorexia nervosa.
70. Acute gastric dilatation in a patient with anorexia nervosa binge/purge subtype.
71. A 53-year-old man with dysphagia, anorexia, and night sweats.
72. A serotonin and melanocortin circuit mediates D-fenfluramine anorexia.
73. Impact of broadening definitions of anorexia nervosa on sample characteristics.
74. Experience with activity based anorexia enhances conditioned taste aversion learning in rats.
75. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast.
76. Effects of Chinese herbal medicine Bushen Shugan Recipe in regulating the hypothalamus-pituitary-ovarian axis in a rat model of stress-induced anorexia.
77. Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa.
78. Refeeding syndrome influences outcome of anorexia nervosa patients in intensive care unit: an observational study.
79. Comment on "adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype".
80. Elevated transaminases as a predictor of coma in a patient with anorexia nervosa: a case report and review of the literature.
81. Management of anorexia and bulimia nervosa: An evidence-based review.
82. Skin signs in anorexia nervosa.
83. Reconstruction-dependent recovery from anorexia and time-related recovery of regulatory ghrelin system in gastrectomized rats.
84. Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT.
85. Hypoglycemic coma in a patient with anorexia nervosa coincident with acute exacerbation of liver injury induced by oral intake of nutrients.
86. Malnutrition and hemodynamic status in adolescents hospitalized for anorexia nervosa.
87. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study.
88. Anorexia nervosa and Wernicke-Korsakoff syndrome: a case report.
89. Emotion brain alterations in anorexia nervosa: a candidate biological marker and implications for treatment.
90. All better? How former anorexia nervosa patients define recovery and engaged in treatment.
91. Serum glutamine, set-shifting ability and anorexia nervosa.
92. Pre-meal anxiety and food intake in anorexia nervosa.
93. Adolescent activity-based anorexia increases anxiety-like behavior in adulthood.
94. Tako-tsubo cardiomyopathy complicated by recurrent torsade de pointes in a patient with anorexia nervosa.
95. Olanzapine in the treatment of adolescents with anorexia nervosa.
96. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia.
97. Decision-making in anorexia nervosa.
98. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity.
99. Association study of 182 candidate genes in anorexia nervosa.
100. Correct diffusing capacity of lung for carbon monoxide and carbon monoxide transfer coefficient in considering respiratory function in patients with stable anorexia nervosa.
101. Modified sham feeding of sweet solutions in women with anorexia nervosa.
102. Neural correlates of viewing photographs of one's own body and another woman's body in anorexia and bulimia nervosa: an fMRI study.
103. Family-based treatment for adolescents with anorexia nervosa: a dissemination study.
104. Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.
105. Feasibility, acceptability, and effectiveness of family-based treatment for adolescent anorexia nervosa: an observational study conducted in Brazil.
106. The functional architecture of dehydration-anorexia.
107. Assessment of serum apelin levels in girls with anorexia nervosa.
108. Estrogen receptor 1 gene (ESR1) is associated with restrictive anorexia nervosa.
109. The impact of weight normalization on quality of recovery in anorexia nervosa.
110. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa.
111. A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.
112. Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa.
113. The management of pneumothorax in patients with anorexia nervosa: A case report and review of the literature.
114. Melatonin, the RANKL/RANK/OPG system, and bone metabolism in girls with anorexia nervosa.
115. Animal models of anorexia and cachexia.
116. Research advance in child anorexia and appetite regulation.
117. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa.
118. NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia.
119. Uniting Couples (in the treatment of) Anorexia Nervosa (UCAN).
120. Severe anorexia nervosa, co-occurring major depressive disorder and electroconvulsive therapy as maintenance treatment: a case report.
121. Choice of diet in patients with anorexia nervosa.
122. Current treatment for anorexia nervosa: efficacy, safety, and adherence.
123. Altered social reward and attention in anorexia nervosa.
124. Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.
125. Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.
126. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.
127. Emotional theory of mind and emotional awareness in recovered anorexia nervosa patients.
128. Unique challenges for appropriate management of a 16-year-old girl with superior mesenteric artery syndrome as a result of anorexia nervosa: a case report.
129. Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.
130. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.
131. Attitudes of patients with anorexia nervosa to compulsory treatment and coercion.
132. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa.
133. Polymorphisms in serotonin-related genes in anorexia nervosa. The first study in Czech population and metaanalyses with previously performed studies.
134. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa.
135. Severe acute liver and pancreas damage in anorexia nervosa.
136. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa.
137. Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample.
138. Childhood anxiety associated with low BMI in women with anorexia nervosa.
139. Behavioral assessment of the reinforcing effect of exercise in women with anorexia nervosa: further paradigm development and data.
140. Adipose tissue distribution after weight restoration and weight maintenance in women with anorexia nervosa.
141. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study.
142. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa.
143. Retraction. Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa.
144. Emotion avoidance in patients with anorexia nervosa: initial test of a functional model.
145. Bone marrow changes in adolescent girls with anorexia nervosa.
146. Prolonged QT interval in a man with anorexia nervosa.
147. Running and addiction: precipitated withdrawal in a rat model of activity-based anorexia.
148. Validity and utility of subtyping anorexia nervosa.
149. The role of anorexia in resistance and tolerance to infections in Drosophila.
150. Respiratory function in patients with stable anorexia nervosa.
151. Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.
152. Family perception of anorexia and bulimia: a systematic review.
153. Fallacies in standardised mortality ratios in anorexia nervosa.
154. Adolescent-onset anorexia nervosa - missing half of the story?
155. Anorexia nervosa.
156. Behavioral management for anorexia nervosa.
157. Anorexia nervosa: an increasing problem in children and adolescents.
158. The ANTOP study: focal psychodynamic psychotherapy, cognitive-behavioural therapy, and treatment-as-usual in outpatients with anorexia nervosa--a randomized controlled trial.
159. Increased bone marrow fat in anorexia nervosa.
160. Commentary to QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.
161. QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.
162. Olanzapine treatment in anorexia nervosa: case report.
163. Substance use disorders in women with anorexia nervosa.
164. Validation of a food frequency questionnaire for determining calcium and vitamin D intake by adolescent girls with anorexia nervosa.
165. Practical therapeutic strategies for anorexia in the elderly.
166. Spirometric parameters in malnourished girls with anorexia nervosa.
167. The effect of bed rest on bone turnover in young women hospitalized for anorexia nervosa: a pilot study.
168. Balance in patients with anorexia and bulimia nervosa.
169. Body composition changes in female adolescents with anorexia nervosa.
170. Epidemiology of anorexia nervosa in men: a nationwide study of Finnish twins.
171. Putting evidence into practice: evidence-based interventions to prevent and manage anorexia.
172. Caffeine, artificial sweetener, and fluid intake in anorexia nervosa.
173. Adolescent-onset anorexia nervosa: 18-year outcome.
174. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa.
175. Trabecular structure analysis of the distal radius in adolescent patients with anorexia nervosa using ultra high resolution flat panel based volume CT.
176. Anorexia nervosa: from purgative behaviour to nephropathy. a case report.
177. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
178. Family-based treatment of a 17-year-old twin presenting with emerging anorexia nervosa: a case study using the "Maudsley method".
179. Excess mortality, causes of death and prognostic factors in anorexia nervosa.
180. Neurobiology of inflammation-associated anorexia.
181. The Genetics of Anorexia Nervosa: Current Findings and Future Perspectives.
182. Hypercholesterolaemia in anorexia nervosa: frequency and changes during refeeding.
183. The endocrinopathies of anorexia nervosa.
184. Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa.
185. Psychiatrists' attitudes towards autonomy, best interests and compulsory treatment in anorexia nervosa: a questionnaire survey.
186. Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents.
187. Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors.
188. Administration of IL-1beta to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract.
189. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa.
190. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT.
191. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.
192. The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer.
193. Anorexia-cachexia syndrome in lung cancer.
194. A case of male anorexia with Klinefelter's syndrome, 22 years later -- case report.
195. Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.
196. Hypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model.
197. Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy.
198. Management of weight loss and anorexia.
199. Eighty-five per cent of what? Discrepancies in the weight cut-off for anorexia nervosa substantially affect the prevalence of underweight.
200. Ethics in anorexia nervosa: autonomy, beneficence or responsibility?.
201. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa.
202. Neural control of the anorexia-cachexia syndrome.
203. Water intoxication in two girls with anorexia nervosa.
204. Cognitive function and brain structure in females with a history of adolescent-onset anorexia nervosa.
205. The role of hypothalamic ingestive behavior controllers in generating dehydration anorexia: a Fos mapping study.
206. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa.
207. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task.
208. Impaired central processing of emotional faces in anorexia nervosa.
209. Heart rate and blood pressure variability and baroreflex sensitivity in patients with anorexia nervosa.
210. Idiopathic achalasia mistakenly diagnosed as anorexia nervosa.
211. PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats.
212. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.
213. Bone metabolism in adolescent boys with anorexia nervosa.
214. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa.
215. Anorexia nervosa: The physiological consequences of starvation and the need for primary prevention efforts.
216. Determinants of height in adolescent girls with anorexia nervosa.
217. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa.
218. Assessing the heritability of anorexia nervosa symptoms using a marginal maximal likelihood approach.
219. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.
220. Chronic pancreatitis in a patient with malnutrition due to anorexia nervosa.
221. Bilateral superficial peroneal nerve entrapment secondary to anorexia nervosa: a case report.
222. Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
223. Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa.
224. Dietary energy density and diet variety as predictors of outcome in anorexia nervosa.
225. Whole-body dual-energy x-ray absorptiometry comes of age: bone structural measures and their physiological determinants in anorexia nervosa.
226. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa.
227. Prevalence of symptoms of anorexia nervosa and dissatisfaction with body image among female adolescents in Florianópolis, Santa Catarina State, Brazil.
228. Psychological and weight-related characteristics of patients with anorexia nervosa-restricting type who later develop bulimia nervosa.
229. Suicide attempts in anorexia nervosa.
230. Information from your family doctor. Anorexia and bulimia: what you should know.
231. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
232. Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy.
233. Prevalence of anorexia nervosa, bulimia nervosa and other eating disorders in adolescent girls in Reus (Spain).
234. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study.
235. Neurobiology of anorexia and bulimia nervosa.
236. Oral health and bone density in adolescents and young women with anorexia nervosa.
237. Colonic tuberculosis clinically misdiagnosed as anorexia nervosa, and radiologically and histopathologically as Crohn's disease.
238. Shared temperament risk factors for anorexia nervosa: a twin study.
239. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1.
240. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II.
241. Toward an understanding of risk factors for anorexia nervosa: a case-control study.
242. Competence to make treatment decisions in anorexia nervosa: thinking processes and values.
243. Measurement of daily activity in restrictive type anorexia nervosa.
244. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa.
245. Is des-acyl ghrelin contributing to uremic anorexia?
246. Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents.
247. Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised controlled trial.
248. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa.
249. Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens.
250. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
251. Regional fat distribution in adolescents with anorexia nervosa: effect of duration of malnutrition and weight recovery.
252. Does desacyl ghrelin contribute to uraemic anorexia?
253. Hypothalamic neuropeptides and appetite response in anorexia-cachexia animal.
254. Megestrol acetate in cachexia and anorexia.
255. A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
256. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype.
257. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
258. Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals.
259. The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior.
260. Biventricular assist device in extreme anorexia nervosa.
261. The eye and anorexia nervosa. A case report.
262. Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses.
263. Role for glutathione in the hyposensitivity of LPS-pretreated mice to LPS anorexia.
264. Cognitive remediation therapy for patients with anorexia nervosa: preliminary findings.
265. Does percent body fat predict outcome in anorexia nervosa?
266. Neural network interactions and ingestive behavior control during anorexia.
267. The impact of hyperactivity and leptin on recovery from anorexia nervosa.
268. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa.
269. Anorexia nervosa.
270. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin.
271. Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa.
272. Development and treatment of anorexia nervosa in patients with Turner syndrome. A case study.
273. Anorexia nervosa and refeeding syndrome. A case report.
274. Case report: comorbid anorexia nervosa and schizophrenia in a male patient.
275. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa.
276. The pursuit of thinness: an outcome study of anorexia nervosa.
277. Hormonal and psychological factors linked to the increased thermic effect of food in malnourished fasting anorexia nervosa.
278. Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa.
279. Endocr J. 2007 Apr;54(2):319-27. Epub 2007 Mar 6. Retraction in: Endocr J. 2009;56(5):726.
280. Pneumomediastinum: a rare complication of anorexia nervosa in children and adolescents. A case study and review of the literature.
281. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients.
282. Skeletal measurements by quantitative ultrasound in adolescents and young women with anorexia nervosa.
283. Psycho-education about osteoporosis in anorexia nervosa patients.
284. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea.
285. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration.
286. Bone cross-sectional geometry in adolescents and young women with anorexia nervosa: a hip structural analysis study.
287. Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines.
288. Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy.
289. Outcome and prognostic factors for adolescent female in-patients with anorexia nervosa: 9- to 14-year follow-up.
290. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents.
291. Reinforcement value and substitutability of sucrose and wheel running: implications for activity anorexia.
292. The refusal of treatment in anorexia nervosa, an ethical conflict with three characters: "the girl, the family and the medical profession". Discussion in a French legislative context.
293. Anorexia nervosa and brain tumor in a 14-year-old girl.
294. Energy expenditure adjusted for body composition differentiates constitutional thinness from both normal subjects and anorexia nervosa.
295. Bone mineral density in bulimic women--influence of endocrine factors and previous anorexia.
296. Anorexia in cancer: role of feeding-regulatory peptides.
297. MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta.
298. Determinants of skeletal loss and recovery in anorexia nervosa.
299. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons.
300. Images in cardiovascular medicine. Left ventricular hypertrophy and outflow tract obstruction in a patient with anorexia nervosa.
301. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
302. Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the "anorexia of aging".
303. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
304. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.
305. The Maudsley family-based treatment for adolescent anorexia nervosa.
306. Anorexia nervosa and mitochondrial neurogastrointestinal encephalomyopathy in male.
307. Obsessive-compulsive disorder and anorexia nervosa in a high school athlete: a case report.
308. Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-induced anorexia.
309. Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management.
310. Editorial: from gut to mind--hormonal satiety signals and anorexia nervosa.
311. The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
312. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa.
313. Personality subtypes and cognitive impairment in anorexia nervosa.
314. Severe renal failure and nephrocalcinosis in anorexia nervosa.
315. Acute oligo-anuric renal failure during the course of non-fulminant hepatitis A in a patient with anorexia nervosa.
316. What is the role of pharmacotherapy in the treatment of anorexia nervosa?
317. Retrospective study of anorexia nervosa: reduced mortality and stable recovery rates.
318. Elevated peptide YY levels in adolescent girls with anorexia nervosa.
319. Experience of caring for someone with anorexia nervosa: qualitative study.
320. Superficial collections of fluid tophaceous material as clinical presentation of anorexia nervosa.
321. Dying to be thin: attachment to death in anorexia nervosa.
322. Anorexia, seizures, and ST-T abnormalities in a morbidly obese 21-year-old man with the Down syndrome.
323. Review article: anorexia and cachexia in gastrointestinal cancer.
324. Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates.
325. Letter re: alendronate in anorexia nervosa.
326. Phobic memory and somatic vulnerabilities in anorexia nervosa: a necessary unity?
327. Does anorexia nervosa occur in the prepubertal years?
328. Anorexia/cachexia-related quality of life for children with cancer.
329. Eating behavior among women with anorexia nervosa.
330. Glucose tolerance predicts short-term refeeding outcome in females with anorexia nervosa.
331. Anorexia nervosa and emphysema.
332. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents.
333. Severe renal failure and nephrocalcinosis in anorexia nervosa.
334. A cybernetic approach to osteoporosis in anorexia nervosa.
335. Body fat redistribution after weight gain in women with anorexia nervosa.
336. Depression in anorexia nervosa: a risk factor for osteoporosis.
337. Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi.
338. Association of multiple DRD2 polymorphisms with anorexia nervosa.
339. Refeeding oedema in anorexia nervosa.
340. Anorexia nervosa in Singapore: an eight-year retrospective study.
341. Hypothalamic neuronal histamine modulates febrile response but not anorexia induced by lipopolysaccharide.
342. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.
343. Inducing sensory stimulation in treatment of anorexia nervosa.
344. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery.
345. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents.
346. Ampulla cardiomyopathy after hypoglycemia in three young female patients with anorexia nervosa.
347. Gelatinous degeneration of the bone marrow in anorexia nervosa.
348. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
349. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents.
350. Knowledge of oral and physical manifestations of anorexia and bulimia nervosa among dentists and dental hygienists.
351. L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain.
352. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.
353. A primer on psychotherapy treatment of anorexia nervosa in adolescents.
354. Eating disorders, especially anorexia nervosa, are associated with an increased risk of attempted suicide in young women.
355. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations.
356. Risk and supervised exercise: the example of anorexia to illustrate a new ethical issue in the traditional debates of medical ethics.
357. Testosterone administration in women with anorexia nervosa.
358. Anorexia nervosa remission following left thalamic stroke.
359. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa.
360. Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa.
361. Factors associated with the increase in resting energy expenditure during refeeding in malnourished anorexia nervosa patients.
362. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls.
363. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa.
364. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa.
365. Video-assisted thoracic surgery for pulmonary aspergilloma in patients with anorexia nervosa.
366. Improvement of nutritional status as assessed by multifrequency BIA during 15 weeks of refeeding in adolescent girls with anorexia nervosa.
367. Impaired osmoregulation in anorexia nervosa: a case-control study.
368. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism.
369. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
370. Anorexia nervosa among female secondary school students in Ghana.
371. Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats.
372. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity.
373. Involvement of endogenous vasopressin in high plasma osmolality-induced anorexia via V1 receptor-mediated mechanism.
374. Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects.
375. Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study.
376. Effects of risedronate on bone density in anorexia nervosa.
377. Total serum cholesterol and suicidality in anorexia nervosa.
378. Resting tachycardia, a warning sign in anorexia nervosa: case report.
379. Early emphysema in patients with anorexia nervosa.
380. Recurrent acute pancreatitis in anorexia and bulimia.
381. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity.
382. A male anorexia nervosa case and its discussion from dynamic point of view.
383. Two young female patients with anorexia nervosa complicated by Mycobacterium tuberculosis infection.
384. Is anorexia nervosa a subtype of body dysmorphic disorder? Probably not, but read on...
385. Short-term secretory regulation of the active form of ghrelin and total ghrelin during an oral glucose tolerance test in patients with anorexia nervosa.
386. Hematologic and metabolic abnormalities in a patient with anorexia nervosa.
387. Plasma ghrelin concentrations, food intake, and anorexia in liver failure.
388. Failure to thrive and cognitive development in toddlers with infantile anorexia.
389. Management of anorexia nervosa revisited: drug treatment suggestions are questionable.
390. Management of anorexia nervosa revisited: emphasis needs to continue to shift to outpatient care.
391. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations.
392. Information from your family doctor. Anorexia nervosa.
393. Anorexia protocolis.
394. Inhibin B: a potential marker of gonadal activity in patients with anorexia nervosa during weight recovery.
395. Adiponectin in anorexia nervosa and bulimia nervosa.
396. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls.
397. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
398. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
399. Effect of Cryptobia salmositica-induced anorexia on feeding behavior and immune response in juvenile rainbow trout Oncorhynchus mykiss.
400. Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa.
401. Management of anorexia nervosa revisited.
402. Anorexia nervosa and chronic renal insufficiency: a prescription for disaster.
403. Cutaneous manifestations in male anorexia nervosa: four cases.
404. Adolescent-onset anorexia nervosa
405. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism.
406. Mitral valve prolapse is a frequent cardiovascular finding in patients with anorexia nervosa.
407. Abnormalities of the respiratory function and control of ventilation in patients with anorexia nervosa.
408. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation.
409. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa.
410. Suicide and attempted suicide in anorexia nervosa and bulimia nervosa.
411. Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype).
412. Minireview: From anorexia to obesity--the yin and yang of body weight control.
413. Serum osteoprotegerin in adolescent girls with anorexia nervosa.
414. Pheromone-induced anorexia in male Syrian hamsters.
415. Cardiac disorders in young women with anorexia nervosa.
416. Anorexia nervosa: a disease with potentially lethal repercussions on the heart.
417. An anorexia nervosa case and an approach to this case with pharmacotherapy and psychodrama techniques.
418. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa.
419. Regional body composition in adolescents with anorexia nervosa and changes with weight recovery.
420. Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa.
421. Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature.
422. Anorexia nervosa during pregnancy.
423. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis.
424. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism.
425. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa.
426. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.
427. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
428. Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa.
429. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
430. The effect of fermented milk on interferon production in malnourished children and in anorexia nervosa patients undergoing nutritional care.
431. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia.
432. Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa.
433. Insulinogenic index at 15 min as a marker of nutritional rehabilitation in anorexia nervosa.
434. Leptin-induced weight loss is not solely mediated by anorexia.
435. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women.
436. Anorexia nervosa with binge eating: a case report.
437. Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.
438. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
439. Pharmacological and non-pharmacological interventions improve food intake in cancer related anorexia and cachexia.
440. Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings.
441. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa.
442. Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances.
443. Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
444. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region.
445. Randomized controlled trial of a treatment for anorexia and bulimia nervosa.
446. Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus.
447. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia.
448. Tumorus anorexia/cachexia syndrome
449. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.
450. One half of patients with anorexia nervosa fully recovered after 21 years but the other half had a chronic or lethal course.
451. Anodipsia nervosa a variant of anorexia in patients with end-stage renal disease.
452. Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment.
453. Analysis of microsatellite markers at the UCP2/UCP3 locus on chromosome 11q13 in anorexia nervosa.
454. Linkage analysis of anorexia nervosa incorporating behavioral covariates.
455. Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients.
456. The variable presentation and early recognition of anorexia nervosa in Hong Kong.
457. Body composition changes in patients with anorexia nervosa after complete weight recovery.
458. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.
459. The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres.
460. Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa.
461. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study.
462. Evidence for a susceptibility gene for anorexia nervosa on chromosome 1.
463. Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
464. Serum amino acids in dialysis patients: the tryptophan/serotonin disorder hypothesis and implications for uremic anorexia.
465. Progressive anorexia and chronic ascites after termination of CAPD.
466. Body composition in adolescents with anorexia nervosa.
467. The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.
468. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging.
469. ABC of the upper gastrointestinal tract: Anorexia, nausea, vomiting, and pain.
470. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.
471. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa.
472. Can family-based treatment of anorexia nervosa be manualized?
473. Eating behavior in anorexia nervosa--an excess of both orexigenic and anorexigenic signalling?
474. Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting.
475. Impact of anorexia, bulimia and obesity on the gynecologic health of adolescents.
476. Hyperbaric oxygen for anorexia nervosa.
477. Magnetic resonance spectroscopic and relaxometric determination of bone marrow changes in anorexia nervosa.
478. A one-year follow-up study in anorexia nervosa. Dietary pattern and anthropometrical evolution.
479. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats.
480. Serum leptin, gonadotropin, and testosterone concentrations in male patients with anorexia nervosa during weight gain.
481. Psychological therapies in anorexia nervosa.
482. Psychological therapies in anorexia nervosa.
483. Psychological therapies in anorexia nervosa.
484. Anorexia nervosa.
485. Cytokine and cyclooxygenase-2 protein in brain areas of tumor-bearing mice with prostanoid-related anorexia.
486. Decreases in blood perfusion of the anterior cingulate gyri in Anorexia Nervosa Restricters assessed by SPECT image analysis.
487. Cytokines and anorexia nervosa.
488. Anorexia nervosa with ischemic necrosis of the segmental ileum and cecum.
489. Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa.
490. Body composition and anorexia nervosa: does physiology explain psychology?
491. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
492. Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?
493. Association between an agouti-related protein gene polymorphism and anorexia nervosa.
494. Hypophosphataemia in anorexia nervosa.
495. The prediction of basal metabolic rate in female patients with anorexia nervosa.
496. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients.
497. Molecular mechanisms in the brain involved in the anorexia of branched-chain amino acid deficiency.
498. Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments.
499. Uremic anorexia: a consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis.
500. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.
501. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat.
502. Relation between basal metabolic rate and body composition in subjects with anorexia nervosa.
503. Body composition of anorexia nervosa patients assessed by underwater weighing and skinfold-thickness measurements before and after weight gain.
504. Compulsory treatment in anorexia nervosa.
505. Impact of hospitalisation on the outcome of adolescent anorexia nervosa.
506. Parental high concern and adolescent-onset anorexia nervosa. A case-control study to investigate direction of causality.
507. Anorexia following termination of pregnancy and laproscopic sterilization.
508. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.
509. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa.
510. Hospitalisation and adolescent anorexia nervosa.
511. Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa.
512. Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa.
513. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
514. Anorexia nervosa: treatment with olanzapine.
515. Better clinical management of anorexia nervosa in teens.
516. Basal metabolic rate in anorexia nervosa: relation to body composition and leptin concentrations.
517. Causes of anorexia in untreated hyperthyroidism: a prospective study.
518. Longitudinal changes of circadian leptin, insulin and cortisol plasma levels and their correlation during refeeding in patients with anorexia nervosa.
519. Medical complications occurring in adolescents with anorexia nervosa.
520. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
521. White muscle disease in humans: myopathy caused by selenium deficiency in anorexia nervosa under long term total parenteral nutrition.
522. The effects of anorexia nervosa on bone metabolism in female adolescents.
523. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
524. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide.
525. Serum leptin levels in patients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters.
526. Cancer anorexia-cachexia syndrome: are neuropeptides the key?
527. Altered dopamine activity after recovery from restricting-type anorexia nervosa.
528. Anorexia nervosa: changes in sexuality during weight restoration.
529. Changes in neuropeptide Y receptors and pro-opiomelanocortin in the anorexia (anx/anx) mouse hypothalamus.
530. Anorexia nervosa with severe liver dysfunction and subsequent critical complications.
531. Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia.
532. Changes in plasma concentrations of leptin and body fat composition during weight restoration in anorexia nervosa.
533. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis.
534. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.
535. Decreased serum levels of acid-labile subunit in patients with anorexia nervosa.
536. Capacity to produce cytokines during weight restoration in patients with anorexia nervosa.
537. Role of cholecystokinin in the anorexia produced by duodenal delivery of peptone in rats.
538. Effect of hormone replacement therapy on bone density in a patient with severe osteoporosis caused by anorexia nervosa.
539. Anorexia nervosa: an important cause of chronic tubulointerstitial nephropathy.
540. Anorexia nervosa treated in a foster house setting: a case report.
541. Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.
542. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa.
543. Riboflavin and riboflavin-derived cofactors in adolescent girls with anorexia nervosa.
544. Weaning anorexia may contribute to local inflammation in the piglet small intestine.
545. Empirical comparison of two psychological therapies. Self psychology and cognitive orientation in the treatment of anorexia and bulimia.
546. Role of central melanocortins in endotoxin-induced anorexia.
547. Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice.
548. Abdominal pain with anorexia in patients with breast carcinoma.
549. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome.
550. Anorexia nervosa with left atrial failure.
551. Eating disorders revisited. I: Anorexia nervosa.
552. Anorexia in patients with chronic renal failure--progress towards understanding the molecular basis.
553. Turner's syndrome, anorexia nervosa, and anabolic steroids.
554. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding.
555. Prolonged acute renal failure after i.v. immunoglobulin therapy in the refeeding phase of anorexia nervosa.
556. The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers.
557. Unusual accumulation of glycogen in liver parenchymal cells in a patient with anorexia nervosa.
558. Glycogen and liver dysfunction in anorexia nervosa.
559. Preservation of macronutrient preferences in cancer anorexia.
560. Is anorexia nervosa associated with elevated rates of suicide?
561. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP.
562. Should patients with anorexia nervosa receive palliative care?
563. Does palliative care have a role in treatment of anorexia nervosa? We should strive to keep patients alive.
564. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.
565. Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting.
566. Interleukin-1beta-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia.
567. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
568. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding.
569. Obsessionality in anorexia nervosa: the moderating influence of exercise.
570. Lack of relation between culture and anorexia nervosa--results of an incidence study on Curaçao.
571. Elevation of serum aminotransferase as a sign of multiorgan-disorders in severely emaciated anorexia nervosa.
572. Leptin in anorexia nervosa.
573. Diffuse soft tissue emphysema as a complication of anorexia nervosa.
574. Technetium-99m-HMPAO brain SPECT in anorexia nervosa.
575. Changes in the glycosylation pattern of circulating gonadotropins after acute administration of gonadotropin-releasing hormone in patients with anorexia nervosa.
576. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.
577. ABC of palliative care. Anorexia, cachexia, and nutrition.
578. Spontaneous nocturnal growth hormone secretion in anorexia nervosa.
579. Anorexia of aging: physiologic and pathologic.
580. Interactions between nutrition and immunity in anorexia nervosa: a 1-y follow-up study.
581. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
582. Increase in diet-induced thermogenesis at the start of refeeding in severely malnourished anorexia nervosa patients.
583. Dyspnoea, anorexia and weight loss in a 74 year old man.
584. Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity.
585. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.
586. Refeeding improves muscle performance without normalization of muscle mass and oxygen consumption in anorexia nervosa patients.
587. A case of non-insulin-dependent diabetes mellitus associated with anorexia nervosa.
588. Changes in body composition and fat distribution after short-term weight gain in patients with anorexia nervosa.
589. High court detains girl with anorexia.
590. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.
591. Integrative approach to management of anorexia nervosa : a case report.
592. Orbital fat edema in anorexia nervosa: a reversible finding.
593. Anorexia nervosa with recurrent hypoglycemic coma and cerebral hemorrhage.
594. Anorexia nervosa.
595. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
596. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients.
597. Distribution of serouslike bone marrow changes in the lower limbs of patients with anorexia nervosa: predominant involvement of the distal extremities.
598. Treating anorexia nervosa. Psychiatrists have mixed views on use of terminal care for anorexia nervosa.
599. Treating anorexia nervosa. Patients' beliefs hinder treatment.
600. Bulimia and anorexia nervosa in winter depression: lifetime rates in a clinical sample.
601. Anorexia nervosa--diagnosis, aetiology, and treatment.
602. Occult intracranial tumours masquerading as early onset anorexia nervosa.
603. Treating anorexia nervosa.
604. Olfactory identification ability in anorexia nervosa.
605. Effects of anorexia nervosa on bone density.
606. Neuropeptide Y and the development of cancer anorexia.
607. Hypoglycaemia and anorexia nervosa.
608. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids.
609. Protein repletion and treatment in anorexia nervosa.
610. Resting metabolic rate of anorexia nervosa patients during weight gain.
611. Severe hypophosphataemia in anorexia nervosa.
612. Weight cycling alters the effects of D-fenfluramine on susceptibility to activity-based anorexia.
613. Use of pelvic ultrasound to monitor ovarian and uterine maturity in childhood onset anorexia nervosa.
614. Anorexia nervosa with soft-tissue emphysema in multiple locations.
615. QT interval in anorexia nervosa.
616. Anorexia nervosa and necrotizing colitis: case report and review of the literature.
617. Activity anorexia: An interplay between basic and applied behavior analysis.
618. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
619. Cardiac abnormalities in young women with anorexia nervosa.
620. Protein repletion and treatment in anorexia nervosa.
621. Anorexia nervosa in a long-term perspective: results of the Heidelberg-Mannheim Study.
622. Assessment of emaciation in relation to threat to life in anorexia nervosa.
623. Normal gastric antral myoelectrical activity in early onset anorexia nervosa.
624. Activity of the hypothalamic-pituitary-adrenal axis is elevated in rats with activity-based anorexia.
625. Sex-hormone-binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa.
626. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.
627. Oesophageal achalasia mistaken for anorexia nervosa.
628. Ventilatory dysfunction in severe anorexia nervosa.
629. Oesophageal achalasia mistaken for anorexia nervosa.
630. Oesophageal achalasia mistaken for anorexia nervosa.
631. Oesophageal achalasia in adolescent women mistaken for anorexia nervosa.
632. A case of anorexia nervosa with acute renal failure induced by rhabdomyolysis; possible involvement of hypophosphatemia or phosphate depletion.
633. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system.
634. Potential regulators of feeding behavior in anorexia nervosa.
635. A three-year prospective study of life events and course for adults with anorexia nervosa/bulimia nervosa.
636. Lack of systematic effects of the 5-hydroxytryptamine 3 receptor antagonist ICS 205-930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa.
637. The clinical features of late onset anorexia nervosa.
638. Family therapy for anorexia nervosa--why not?
639. Biogenic amines in anorexia nervosa: circadian rhythm in urinary excretion and influence of posture and physical task load on plasma catecholamines.
640. Family therapy for anorexia nervosa in adolescence: a review.
641. The ethics of forced feeding in anorexia nervosa.
642. The ethics of forced feeding in anorexia nervosa: a response to Hébert and Weingarten.
643. Hypoglycaemia associated with anorexia nervosa.
644. Total daily energy expenditure and activity level in anorexia nervosa.
645. The ethics of forced feeding in anorexia nervosa.
646. Acrocyanosis in anorexia nervosa.
647. Severe hypophosphataemia during binge eating in anorexia nervosa.
648. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
649. Rare type of visceral myopathy mimicking anorexia nervosa.
650. Skeletal and body-composition effects of anorexia nervosa.
651. Goethe's Ottilie: an early 19th century description of anorexia nervosa.
652. Anorexia nervosa associated with acromegaloid features, onset of acrocyanosis and Raynaud's phenomenon and worsening of chilblains.
653. Compliance and outcome in anorexia nervosa.
654. Interrelationship between serum muscle enzymes and a low T3 in anorexia nervosa.
655. Anorexia nervosa complicating inflammatory bowel disease.
656. Personality features of women with good outcome from restricting anorexia nervosa.
657. Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma.
658. Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa.
659. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat.
660. Anorexia nervosa, Felix Deutsch, and the associative anamnesis: a psychosomatic kaleidoscope.
661. Clinical evaluation of hypokalemia in anorexia nervosa.
662. Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery.
663. Preventing mitral valve prolapse in anorexia nervosa.
664. The course of anorexia nervosa.
665. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins.
666. Anorexia nervosa and bulimia nervosa.
667. Microcalorimetric study of muscle and platelet thermogenesis in anorexia nervosa and bulimia.
668. Anorexia nervosa and food avoidance emotional disorder.
669. Anorexia nervosa or not? A case presentation.
670. Chronic TNF infusion causes anorexia but not accelerated nitrogen loss.
671. Addison's disease presenting as anorexia nervosa in a young man.
672. Anorexia nervosa with elevated serum TSH.
673. Hypothalamic tumour presenting as anorexia nervosa.
674. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
675. Anorexia nervosa.
676. Abnormal perception of food size in anorexia nervosa.
677. Relative importance of calorie intake needed to gain weight and level of physical activity in anorexia nervosa.
678. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa.
679. Anorexia nervosa in a 70 year old man.
680. Intrauterine growth and neonatal weight gain in babies of women with anorexia nervosa.
681. Crohn's disease presenting as anorexia nervosa.
682. Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa.
683. Catecholamine and thyroid hormone metabolism in a case of anorexia nervosa.
684. Crohn's disease presenting as anorexia nervosa.
685. Occult mineral oil pneumonitis in anorexia nervosa.
686. Glucagon secretion in anorexia nervosa.
687. Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa.
688. Anorexia nervosa in a 67 year old woman.
689. Long term follow up of patients with early onset anorexia nervosa.
690. Intraoperative cardiac dysrhythmias in a patient with bulimic anorexia nervosa.
691. Refeeding hypophosphataemia in anorexia nervosa and alcoholism.
692. Stress fractures and reduced bone mineral density with prior anorexia nervosa.
693. Refeeding hypophosphataemia in anorexia nervosa and alcoholism.
694. Reversible bone loss in anorexia nervosa.
695. The significance of learned food aversions in the aetiology of anorexia associated with cancer.
696. Cardiovascular findings in adolescent inpatients with anorexia nervosa.
697. Radionuclide gastric emptying studies in patients with anorexia nervosa.
698. Socio-cultural factors in anorexia nervosa.
699. Two cases of anorexia nervosa associated with Graves' disease.
700. Early onset anorexia nervosa.
701. Perspectives on the prevention of anorexia nervosa and bulimia.
702. Anorexia nervosa and pancreatic ascites.
703. Detecting and managing anorexia nervosa and bulimia in adolescents.
704. Zinc state in anorexia nervosa.
705. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa.
706. Zinc supplementation in anorexia nervosa.
707. Caloric intake necessary for weight maintenance in anorexia nervosa: nonbulimics require greater caloric intake than bulimics.
708. Long-term follow-up of anorexia nervosa.
709. Effect of caffeine sodium benzoate, ketamine hydrochloride, and yohimbine hydrochloride on xylazine hydrochloride-induced anorexia in white-tailed deer.
710. Cell-mediated immunity in anorexia nervosa.
711. Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa.
712. Iodide-induced hypothyroidism in a patient with anorexia nervosa.
713. Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa.
714. Alterations in vitamin A and thyroid hormone status in anorexia nervosa and associated disorders.
715. Changes in somatomedin activity in anorexia nervosa.
716. Responses to epinephrine in patients with anorexia nervosa.
717. Parabiotic transfer of cancer anorexia/cachexia in male rats.
718. Creatine clearance in anorexia nervosa.
719. Responses of pituitary and adrenal medulla to insulin-induced hypoglycemia in patients with anorexia nervosa.
720. Neuropathy and myopathy in two patients with anorexia and bulimia nervosa.
721. Low levels of zinc in hair and blood, pica, anorexia, and poor growth in Chinese preschool children.
722. Spontaneous pneumomediastinum: a complication of anorexia nervosa?
723. Thymulin (Zn-facteur thymique serique) activity in anorexia nervosa patients.
724. Premature loss of bone in chronic anorexia nervosa.
725. Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa.
726. Anorexia and bulimia support group helping victims' families.
727. Premature loss of bone in chronic anorexia nervosa.
728. Premature loss of bone in chronic anorexia nervosa.
729. Anorexia nervosa and necrotizing colitis.
730. Acute pancreatitis and gastric dilatation in a patient with anorexia nervosa.
731. Gastrointestinal disturbance in anorexia nervosa.
732. Intracerebroventricular injection of 125I-salmon calcitonin in rats: fate, anorexia and hypocalcemia.
733. Diminished creatinine clearance in anorexia nervosa: reversal with weight gain.
734. Body composition changes during recovery from anorexia nervosa: comparison of two dietary regimes.
735. Excretion of urinary catecholamine metabolites in anorexia nervosa: effect of body composition and energy intake.
736. General and family practice-important advances in clinical medicine: anorexia nervosa.
737. Quetelet index in diagnosis of anorexia nervosa.
738. Anorexia nervosa and bulimia: problems of "the pleasing child".
739. Total body water and total body potassium in anorexia nervosa.
740. Dietary patterns in anorexia nervosa.
741. Quetelet index in diagnosis of anorexia nervosa.
742. Comparison between weight-preoccupied women and anorexia nervosa.
743. Anorexia nervosa presenting as reversible hypoglycaemic coma.
744. Weight gain and nutritional efficacy in anorexia nervosa.
745. Anorexia nervosa associated with energy-wasting disorders.
746. Xylazine hydrochloride-induced anorexia in white-tailed deer.
747. Anorexia nervosa in black adolescents.
748. Anorexia nervosa.
749. Anorexia nervosa.
750. Anorexia nervosa.
751. Anorexia nervosa.
752. A comparison between muscle function and body composition in anorexia nervosa: the effect of refeeding.
753. Quantitative assessment of psychologic state of patients with anorexia nervosa or bulimia: response to caloric stimulus.
754. Role of whole-body lipids and nitrogen as limiting factors for survival in tumor-bearing mice with anorexia and cachexia.
755. Anorexia nervosa: a lifestyle disorder.
756. High calorie supplements for patients with anorexia nervosa.
757. Covert diuretic use and anorexia nervosa.
758. Anorexia nervosa and a bearded female saint.
759. Calcitonin-induced anorexia in rats: a structure-activity study by intraventricular injections.
760. Anorexia and antagonism of thiamin utilization in poultry treated with furazolidone.
761. Is taste related to anorexia in cancer patients?
762. Anorexia nervosa occurring in patients with diabetes mellitus.
763. Immunocompetency in anorexia nervosa.
764. Reduced alternative complement pathway control protein levels in anorexia nervosa: response to parenteral alimentation.
765. Family issues in the pathogenesis of anorexia nervosa.
766. Endocrine disturbances in anorexia nervosa and depression.
767. Hyperalimentation in treatment of anorexia nervosa.
768. Physiological and psychological mechanisms of cancer anorexia.
769. Naloxone in anorexia nervosa.
770. An immunological assessment of patients with anorexia nervosa.
771. Acute gastric dilatation with infarction and perforation. Report of fatal outcome in patient with anorexia nervosa.
772. Chronic anorexia nervosa: medical mimic.
773. Chlorosis, anaemia, and anorexia nervosa.
774. Anorexia nervosa, liquorice and hypokalaemic myopathy.
775. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa.
776. Naloxone in anorexia nervosa: role of the opiate system.
777. The relation of personality characteristics to body image disturbances in juvenile anorexia nervosa: a multivariate analysis.
778. Anorexia nervosa with herpes simplex encephalitis.
779. Evaluation of anorexia as the cause of altered protein synthesis in skeletal muscles from nongrowing mice with sarcoma.
780. Disturbances of sex hormones in anorexia nervosa in the male.
781. A "pubertal" 24-hour luteinizing hormone (LH) secretory pattern following weight loss in the absence of anorexia nervosa.
782. Chlorosis, anaemia, and anorexia nervosa.
783. Naloxone in the treatment of anorexia nervosa: effect on weight gain and lipolysis.
784. Cataract formation in anorexia nervosa.
785. Chlorosis, anaemia, and anorexia nervosa.
786. Oral L-histidine fails to reduce taste and smell acuity but induces anorexia and urinary zinc excretion.
787. Chlorosis, anaemia, and anorexia nervosa.
788. Epidemiology of anorexia nervosa in Monroe County, New York: 1960-1976.
789. Anorexia nervosa in diabetes mellitus.
790. Altered thresholds for thermoregulatory sweating and vasodilatation in anorexia nervosa.
791. An evaluation of trace metals, vitamins, and taste function in anorexia nervosa.
792. DNA-synthesis-stimulating activity in the sera of anorexia nervosa.
793. Anorexia nervosa in diabetes mellitus.
794. Anorexia nervosa in diabetes mellitus.
795. Interrelations among amenorrhea, serum gonadotropins and body weight in anorexia nervosa.
796. Concurrence of anorexia nervosa and yellow mutant albinism.
797. Anorexia of infection as a mechanism of host defense.
798. Caloric requirements for weight gain in anorexia nervosa.
799. Weight and skeletal maturation - a study of radiological and chronological age in an anorexia nervosa population.
800. Anorexia of infection as a mechanism of host defense.
801. Spontaneous pneumomediastinum complicating anorexia nervosa.